Outset Medical, Inc. is projected to rise to $6.24 by 2027, a +42% move from its current price of $4.39. OM is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 12 | $4.13 | $4.39 | $4.67 | +0.09% |
| Jul 13 | $4.03 | $4.40 | $4.80 | +0.18% |
| Jul 14 | $3.96 | $4.40 | $4.89 | +0.27% |
| Jul 15 | $3.90 | $4.41 | $4.98 | +0.36% |
| Jul 16 | $3.85 | $4.41 | $5.06 | +0.45% |
| Jul 17 | $3.80 | $4.41 | $5.13 | +0.54% |
| Jul 18 | $3.76 | $4.42 | $5.20 | +0.63% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $3.76 | $4.42 | $5.20 | +0.63% |
| Week 2 | $3.54 | $4.45 | $5.59 | +1.27% |
| Week 3 | $3.38 | $4.47 | $5.92 | +1.92% |
| Week 4 | $3.26 | $4.50 | $6.23 | +2.56% |
| Week 5 | $3.15 | $4.53 | $6.51 | +3.21% |
| Week 6 | $3.07 | $4.56 | $6.78 | +3.87% |
| Week 7 | $2.99 | $4.59 | $7.05 | +4.53% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Outset Medical, Inc. is a medical technology company that develops a hemodialysis system for use in the United States. Its Tablo Hemodialysis System is a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities.
The company manufactures, supports, and distributes the Tablo console, Tablo cartridge, and other consumables, and offers Tablo Data Ecosystem including TabloHub, MyTablo, and TabloDash. Outset Medical was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc.
in January 2015. It was incorporated in 2003 and is headquartered in San Jose, California.
The stock is currently priced at $4.30 per share. Its market capitalization is $79.71M and it is ranked 4330.
The stock trades with a 50-day simple moving average of $4.44 and a 200-day simple moving average of $6.06.
The 30-day price range was $2.81 to $6.59, indicating notable volatility.
Forecasts show a path from neutral in 2026 to bullish in 2027 through 2050, with rising average prices and ROI potential in later years (2026 avg $4.30; 2027 avg $6.01; 2028 avg $8.06; 2029 avg $8.46; 2030 avg $7.46; 2031 avg $7.98; 2032 avg $7.65; 2033 avg $9.03; 2034 avg $13.02; 2035 avg $12.62; 2040 avg $17.43; 2050 avg $31.52).
A major floor 28.0% below — a decisive break under it would weaken the trend.
The nearest floor, 8.4% below — buyers have tended to step in here.
The nearest ceiling, 16.2% above — a clean break opens room to run.
A major ceiling 27.5% above — clearing it would confirm fresh momentum.
Key OM support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of OM market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $4.61 | Sell | $4.53 | Sell |
| MA 10 | $4.61 | Sell | $4.58 | Sell |
| MA 20 | $4.58 | Sell | $4.58 | Sell |
| MA 50 | $4.44 | Sell | $4.48 | Sell |
| MA 100 | $4.11 | Buy | $4.72 | Sell |
| MA 200 | $5.95 | Sell | $6.79 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 48.01 | Neutral |
| Stoch RSI (14) | 14.54 | Buy |
| CCI (20) | -40.66 | Neutral |
| Williams %R (14) | -83.75 | Info |
| MACD (12,26,9) | -0.04 | Sell |
| ROC (12) | -6.93 | Sell |
| Bollinger %B (20,2) | 0.37 | Neutral |
| Stochastic %K (14) | 16.25 | Buy |
| TRIX (15) | 0.20 | Buy |
| Awesome (5,34) | 0.01 | Buy |
| Ultimate (7,14,28) | 48.04 | Neutral |
| Momentum (10) | -0.16 | Sell |
| Aroon Osc (25) | 36.00 | Buy |
| Hull MA (9) | 4.39 | Sell |
| ADX (14) | 9.20 | Neutral |
| ATR (14) | 0.25 | Info |
The 30-day technical picture is bearish. RSI14 sits at 50, signaling neither overbought nor oversold conditions.
The price action is trading below the 50-day simple moving average of $4.44 and well below the 200-day simple moving average of $6.06, suggesting limited near-term upside momentum and resistance ahead.
Support is identified at $4.02 and resistance at $5.10, framing a narrow near-term trading band. The 30-day price range spans from $2.81 to $6.59, highlighting elevated volatility in the period.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $3.16 | $4.39 | $6.62 | 0% | Neutral | |
| $4.53 | $6.24 | $9.30 | +42% | Bullish | |
| $5.74 | $8.40 | $13.35 | +91% | Bullish | |
| $5.75 | $8.87 | $14.78 | +102% | Bullish | |
| $4.83 | $7.81 | $13.56 | +78% | Bullish | |
| $5.01 | $8.46 | $15.20 | +93% | Bullish | |
| $4.63 | $8.17 | $15.13 | +86% | Bullish | |
| $5.32 | $9.77 | $18.61 | +123% | Bullish | |
| $7.42 | $14.17 | $27.66 | +223% | Bullish | |
| $6.87 | $13.65 | $27.27 | +211% | Bullish | |
| $8.71 | $19.36 | $42.49 | +341% | Bullish | |
| $15.75 | $35.00 | $80.50 | +697% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $3.16 | $4.39 | $5.79 | +0.00% |
| August 2026 | $3.93 | $4.76 | $6.01 | +8.48% |
| September 2026 | $3.88 | $4.77 | $6.14 | +0.10% |
| October 2026 | $4.16 | $5.17 | $6.78 | +8.50% |
| November 2026 | $4.20 | $5.28 | $7.02 | +2.07% |
| December 2026 | $3.87 | $4.91 | $6.62 | -6.91% |
Click any year to see its month-by-month OM forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The OM price prediction for 2026 points to an average of $4.39 (low $3.16, high $6.62) — a potential gain of 0% on today's $4.39. A consolidation phase looks the most probable path here.
In 2027, OM is projected to trade between $4.53 and $9.30, averaging $6.24 — a potential gain of +42% from today's $4.39. That is up +42% on the projected 2026 average. Momentum favours further upside here.
Outset Medical, Inc.'s 2028 outlook centres on $8.40, within a $5.74 to $13.35 range. That is up +35% on the projected 2027 average. That marks a +91% change versus current levels. Buyers look set to stay in control over this stretch.
By 2029, OM could reach as high as $14.78, with a base case around $8.87 and support toward $5.75 — roughly +102% from $4.39. Momentum favours further upside here.
Expect OM to range from $4.83 to $13.56 through 2030. The $7.81 average target implies a +78% move from current prices. That is -12% versus the projected 2029 average. Buyers look set to stay in control over this stretch.
The OM price prediction for 2031 points to an average of $8.46 (low $5.01, high $15.20) — a potential gain of +93% on today's $4.39. Momentum favours further upside here.
In 2032, OM is projected to trade between $4.63 and $15.13, averaging $8.17 — a potential gain of +86% from today's $4.39. That is -3% versus the projected 2031 average. Buyers look set to stay in control over this stretch.
Outset Medical, Inc.'s 2033 outlook centres on $9.77, within a $5.32 to $18.61 range. That is up +20% on the projected 2032 average. That marks a +123% change versus current levels. Momentum favours further upside here.
By 2034, OM could reach as high as $27.66, with a base case around $14.17 and support toward $7.42 — roughly +223% from $4.39. Buyers look set to stay in control over this stretch.
Expect OM to range from $6.87 to $27.27 through 2035. The $13.65 average target implies a +211% move from current prices. That is -4% versus the projected 2034 average. Momentum favours further upside here.
The OM price prediction for 2040 points to an average of $19.36 (low $8.71, high $42.49) — a potential gain of +341% on today's $4.39. Buyers look set to stay in control over this stretch.
In 2050, OM is projected to trade between $15.75 and $80.50, averaging $35.00 — a potential gain of +697% from today's $4.39. That is up +81% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in OM today (≈ 227.790433 OM) could be worth
$7,972.73
+$6,972.73 (+697%) by 2050 · US Dollar
Based on the average projected OM price of $35 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in OMwould be worth at today's price.
$1,000 invested in OM on Jul 10, 2025 (≈ 48.520134 OM) would be worth
$213
-$787 (-78.7%) today · 0.21× · US Dollar
Based on a OM entry price of $20.61 vs. today's $4.39.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $4.72 | $930.08 | -7.0% |
| 1 month ago | $4.62 | $950.22 | -5.0% |
| 3 months ago | $4.2 | $1,045.24 | +4.5% |
| 6 months ago | $5.57 | $788.15 | -21.2% |
| 1 year ago | $20.61 | $213 | -78.7% |
| All time (5.0y) ago | $673.8 | $6.52 | -99.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our OM forecast.
Our base-case forecast reaches $8.80 around 2029.
Implied market cap at $8.80: $163.13M
Across the multi-year forecast, 2026 is Neutral with an average forecast price of $4.30. From 2027 onward, the outlook shifts to Bullish, with the average forecast rising to $6.01 in 2027, $8.06 in 2028, and $8.46 in 2029, before easing to $7.46 in 2030 and $7.98 in 2031. The longer horizon shows continued upside potential, with 2032 at $7.65, 2033 at $9.03, 2034 at $13.02, and 2035 at $12.62 on average.
The more distant horizons project substantial gains: 2040 average $17.43 and 2050 average $31.52, with corresponding ROI figures of 305.4% and 633.1%. Max values in the forecast rise to $38.27 (2040) and $72.50 (2050), underscoring meaningful upside potential while acknowledging uncertainty inherent in any projection.
These are estimates, not guarantees, and carry inherent investment risk. Investors should consider the full range of outcomes, including potential downside, when evaluating such forecasts.
Tap a question to reveal the answer.
Avg $7.46, min $4.61, max $12.95, ROI 73.5%, sentiment BULLISH.
Forecasts show neutral in 2026 and bullish thereafter, with 2027 avg $6.01, 2028 avg $8.06, 2030 avg $7.46, 2050 avg $31.52 and ROI up to 633.1% in 2050; these are estimates, not guarantees.
Yes—the 2040 forecast shows a max of $38.27 and an average of $17.43.
Current price is $4.30 and market capitalization is $79.71M.
The 30-day range is $2.81 to $6.59.
Outset Medical, Inc. Community Discussion
0Share your Outset Medical, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.